DLD inhibition could have resulted in lower levels of TCA cycle downstream metabolites, and downmodulation of DLD promoted autophagy in melanoma cells, as well as inhibiting tumor growth and proliferation in vivo (Yumnam et al., 2021). The gene discussed is DLD; the disease is melanoma.